Biofarma Group has always believed in scientific cooperation as an essential driver of the ability to innovate and contribute to scientific and technological progress.
This is why the Group has been committed to creating a close network of collaborations with leading research institutes, universities, and scientific institutions for years. Among these, The Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome, the flagship of Italian healthcare and among the first forty best hospitals in the world.
Thanks to this critical collaboration, Biofarma Group has developed its first Biocide: a disinfectant preparation with antimicrobial action for hygienic hand friction.
The story of this project was born in April 2020, when the hand gel and raw materials needed to produce it were missing. They were the first dramatic moments of the pandemic from Covid-19.
In that difficult circumstance, Biofarma Group decided to put itself at the community’s service and donate a supply of gel to hospitals, finding in the Foundation an interlocutor with human sensitivity and a scientific and technical competence that immediately created a harmony between the two realities.
These were the premises that allowed the start of the project that gave birth to the Gemangel Biocide. The formula of this hand disinfectant, PMC, contains glycerine and niacinamide. Once applied, the hands are sanitized but not depleted of their natural barrier. In addition, this formulation does not contain perfumes, dyes, or preservatives, does not require rinsing and dries quickly.
The Biocide, formulated with the Pharmacy Unit of Policlinico Gemelli, has been validated by the Hospital Hygiene Unit, which has carried out all the tests required by ISO standards, including tests for using the product in the operating room. At the same time, Biofarma Group has developed analytical methods and carried out stability tests.
“We are proud of this important project and grateful to the Fondazione Policlinico Gemelli for being at our side in its realization. This is a company of primary importance with which our R&D laboratories have worked in perfect synergy, achieving an important result for the community and our Group” says Germano Scarpa, president of Biofarma Group.
“I express satisfaction with the realization of the project with Biofarma Group: a collaboration born in the critical phase of the pandemic in which it was important to unite all efforts to ensure the supply of sanitizing gels. It is worth noting the value of this union of intentions of two primary private institutions that have worked and work concretely for the collective well-being” says Marco Elefanti, General Manager of the Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
